Insider · CIK 0001363558

Collard Craig A

Reports to the SEC for 5 companies · CARY, NC

sec.gov

Transactions

Companies

Filings

CIK

0001363558

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-31	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+34.8K sh	—	—	856,492
2026-07-31	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−34.8K sh	—	—	347,886
2026-07-30	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+50K sh	—	—	821,703
2026-07-30	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−50K sh	—	—	700,295
2026-07-19	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−13.8K sh	—	—	82,781
2026-07-19	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+13.8K sh	—	—	771,682
2026-06-24	TSNDFTerrAscend Corp. · Employee Share Option (Right to Buy)A Award	Director	AAward	+150K sh	—	—	150,000
2026-06-24	TSNDFTerrAscend Corp. · Employee Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−150K sh	—	—	0
2026-04-30	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−50K sh	—	—	750,316
2026-04-30	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+34.8K sh	—	—	696,841
2026-04-30	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−34.8K sh	—	—	382,675
2026-04-30	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+50K sh	—	—	757,885
2026-04-19	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−13.8K sh	—	—	96,758
2026-04-19	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+13.8K sh	—	—	662,052
2026-04-03	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+62.5K sh	—	—	648,255
2026-04-03	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−62.5K sh	—	—	62,500
2026-01-31	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−34.8K sh	—	—	417,464
2026-01-31	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+34.8K sh	—	—	571,710
2026-01-30	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+800K sh	—	—	800,337
2026-01-30	HRTXHERON THERAPEUTICS, INC. /DE/ · Performance Stock UnitsA Award	Director, Chief Executive Officer	AAward	+800K sh	—	—	800,336
2026-01-19	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+13.8K sh	—	—	536,921
2026-01-19	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−13.8K sh	—	—	110,375
2025-10-31	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+34.8K sh	—	—	523,124
2025-10-31	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−34.8K sh	—	—	452,253
2025-10-19	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−13.8K sh	—	—	124,172
2025-10-19	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+13.8K sh	—	—	488,335
2025-07-31	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+34.8K sh	—	—	474,538
2025-07-31	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−34.8K sh	—	—	487,042
2025-07-19	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−13.8K sh	—	—	137,969
2025-07-19	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+13.8K sh	—	—	439,749
2025-06-24	TSNDFTerrAscend Corp.A Award	Director	AAward	+434K sh	—	—	1,076,538
2025-04-30	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+34.8K sh	—	—	425,952
2025-04-30	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−34.8K sh	—	—	521,831
2025-04-19	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+13.8K sh	—	—	391,163
2025-04-19	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−13.8K sh	—	—	151,766
2025-04-03	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+62.5K sh	—	—	377,367
2025-04-03	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−62.5K sh	—	—	125,000
2025-03-25	TSNDFTerrAscend Corp.F Tax Payment	Director	FTax Payment	−2,258 sh	$0.46	−$1,038.68	642,885
2025-01-31	HRTXHERON THERAPEUTICS, INC. /DE/ · Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+1.11M sh	—	—	1,113,240
2025-01-31	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+557K sh	—	—	556,620
2025-01-19	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−13.8K sh	—	—	165,562
2025-01-19	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+13.8K sh	—	—	314,867
2024-12-31	TSNDFTerrAscend Corp.F Tax Payment	Director	FTax Payment	−71.7K sh	$0.65	−$46.6K	645,143
2024-10-19	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−13.8K sh	—	—	179,359
2024-10-19	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+13.8K sh	—	—	290,387
2024-07-19	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−13.8K sh	—	—	193,156
2024-07-19	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+13.8K sh	—	—	276,590
2024-06-17	TSNDFTerrAscend Corp.A Award	Director	AAward	+163K sh	—	—	716,847
2024-06-17	TSNDFTerrAscend Corp. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−150K sh	—	—	0
2024-06-17	TSNDFTerrAscend Corp. · Share Option (Right to Buy)A Award	Director	AAward	+150K sh	—	—	150,000

Recent filings

Accepted (ET)
Aug 34
Collard Craig A0001193125-26-329694
SEC(opens sec.gov)
Jul 204
Collard Craig A0001193125-26-308958
SEC(opens sec.gov)
Jun 254
Collard Craig A0002064832-26-000248
SEC(opens sec.gov)
May 44
Collard Craig A0001193125-26-203196
SEC(opens sec.gov)
Apr 214
Collard Craig A0001193125-26-165365
SEC(opens sec.gov)
Apr 64
Collard Craig A0001193125-26-144196
SEC(opens sec.gov)
Feb 34
Collard Craig A0001193125-26-034490
SEC(opens sec.gov)
Feb 34
Collard Craig A0001193125-26-034633
SEC(opens sec.gov)

Companies

Address

25 FENTON MAIN STREET SUITE 300

CARY, NC, 27511